Stocks on the Move: Entergy Corporation (ETR), Nielsen Holdings plc (NLSN), DENTSPLY SIRONA Inc. (XRAY)

Entergy Corporation (ETR) managed to rebound with the stock climbing 2.83% or $2 to close the day at $72.77 on active trading volume of 2.36M shares, compared to its three month average trading volume of 1.36M. The New Orleans Louisiana 70113 based company has been outperforming the electric utilities group over the past 52 weeks, with the stock gaining 3.79%, compared to the industry which has advanced 9.24% over the same period. With RSI of 61.81, the stock should still continue to rise and get closer to its one year target estimate of $73.5, making it a hold for now.

Entergy Corporation, together with its subsidiaries, engages in the generation and distribution of electricity in the United States. It operates in two segments, Utility and Entergy Wholesale Commodities. The Utility segment generates, transmits, distributes, and sells electric power in portions of Arkansas, Mississippi, Texas, and Louisiana, including the City of New Orleans; and distributes natural gas. The Entergy Wholesale Commodities segment is engaged in the ownership, operation, and decommissioning of nuclear power plants located in the northern United States; sells the electric power to wholesale customers; offers services to other nuclear power plant owners; and owns interests in non-nuclear power plants that sell the electric power to wholesale customers. This segment sells energy to retail power providers, utilities, electric power co-operatives, power trading organizations, and other power generation companies. It generates electricity through gas/oil, nuclear, coal, wind, and hydro power. The company’s power plants have approximately 30,000 megawatts (MW) of aggregate electric generating capacity, including approximately 10,000 MW of nuclear-fueled capacity. It delivers electricity to 2.8 million utility customers in Arkansas, Louisiana, Mississippi, and Texas. The company was founded in 1989 and is based in New Orleans, Louisiana.

Nielsen Holdings plc (NLSN) climbed 0.09% during last trading as the stock added $0.04 to finish the day at $44.85 with about 2.33M shares changing hands, compared to its three month average trading volume of 3.01M. The $15.62B market cap company, which fluctuated between $44.52 and $44.95 during the day, currently situated 11.35% above its 52 week low of $40.28 and -18.78% away from its one year high of $55.94. The RSI of 71.68 indicates the stock is overbought at the current levels, sell for now.

Nielsen Holdings plc operates as an information and measurement company. The company provides media and marketing information, analytics, and manufacturer and retailer expertise about what and where consumers buy, read, watch and listen. Its Buy segment provides retail transactional measurement data, consumer behavior information, and analytics primarily to businesses in the consumer packaged goods industry. This segment provides data on retail measurement services, such as market share and competitive sales volumes; insights into distribution, pricing, merchandising, and promotion; consumer panel measurement, which offers insight into shopper behavior and customer segmentation; and consumer intelligence and analytical services for decision making in development and marketing cycles. The company’s Watch segment provides viewership and listening data, and analytics primarily to the media and advertising industries for television, radio, digital and mobile viewing, and listening platforms. It offers television audience measurement services, including more than one screen, unduplicated reach, cause and effect analysis, and program viewing behavior testing; audio audience measurement services; digital audience measurement services, such as digital media and market research, audience analytics, and social media measurement; mobile measurement services comprising measurement and consumer research for telecom and media companies; and advertiser solutions. The company was formerly known as Nielsen N.V. and changed its name to Nielsen Holdings plc in August 2015. The company was founded in 1923 and is headquartered in Oxford, the United Kingdom.

DENTSPLY SIRONA Inc. (XRAY) saw its value increase by 0.6% as the stock gained $0.36 to finish the day at a closing price of $60.74. The stock was higher in trading and has fluctuated between $55-$65.83 per share for the past year. The shares, which traded within a range of $60 to $60.76 during the day, are up by 1.42% in the past three months and up by 1.98% over the past six months. It is currently trading 6.08% above its 20 day moving average and 4.6% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $66.5 a share over the next twelve months. The current relative strength index (RSI) reading is 70.18. The technical indicator do not lead us to believe the stock will see more gains any time soon.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

 

Stocks Under Consideration: DENTSPLY SIRONA Inc. (XRAY), Eli Lilly and Company (LLY), Microsoft Corporation (MSFT)

DENTSPLY SIRONA Inc. (XRAY) grew with the stock adding 1.53% or $0.9 to close at $59.74 on active trading volume of 2.23M compared its three months average trading volume of 1.57M. The York Pennsylvania 17405 based company operating under the Medical Instruments & Supplies industry has been trending up for the last 52 weeks, with the shares price now 7.81% up for the period and up by 3.48% so far this year. With price target of $66.5 and a 11.1% rebound from 52-week low, DENTSPLY SIRONA Inc. has plenty of upside potential, making it a hold with a view buy.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Eli Lilly and Company (LLY) had a light trading with around 3.31M shares changing hands compared to its three month average trading volume of 6.11M. The stock traded between $77.25 and $78.83 before closing at the price of $78.81 with 1.34% change on the day. The Indianapolis Indiana 46285 based company is currently trading 23.62% above its 52 week low of $64.18 and -4.08% below its 52 week high of $83.79. Both the RSI indicator and target price of  and $86.35 respectively, lead us to believe that it could rise over the coming weeks.

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. It also provides neuroscience products for the treatment of depressive disorders, diabetic peripheral neuropathic pain, anxiety disorders, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorders; depressive, obsessive-compulsive, bulimia nervosa, and panic disorders; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains. In addition, the company offers products for the treatment of non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products. Further, it provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry; and chewable tablets that kill fleas and prevent flea infestations, heartworm diseases, roundworm diseases, hookworm diseases, and whipworm diseases. Additionally, the company offers products to treat chronic manifestations of atopic dermatitis and congestive heart failure in dogs; and chronic allergic dermatitis and kidney diseases in cats. It has a clinical collaboration agreement with Athenex, Inc.; and a research agreement with AstraZeneca for the development of clinical candidate MEDI1814 as a disease-modifying treatment for Alzheimer’s disease. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Microsoft Corporation (MSFT) saw its value decrease by -0.23% as the stock dropped $-0.15 to finish the day at a closing price of $64.57. The stock was lighter in trading and has fluctuated between $48.04-$65.91 per share for the past year. The shares, which traded within a range of $64.02 to $64.72 during the day, are up by 10.14% in the past three months and up by 12.55% over the past six months. It is currently trading 1.39% above its 20 day moving average and 2.75% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $68.97 a share over the next twelve months. The current relative strength index (RSI) reading is 59.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Microsoft Corporation, a technology company, develops, licenses, and supports software products, services, and devices worldwide. The company’s Productivity and Business Processes segment offers Office 365 commercial products and services for businesses, including Office, Exchange, SharePoint, and Skype, as well as related Client Access Licenses (CALs); Office 365 consumer services, such as Skype, Outlook.com, and OneDrive; Dynamics business solutions, such as financial management, customer relationship management, supply chain management, and analytics applications for small and mid-size businesses, large organizations, and divisions of enterprises; and LinkedIn online professional network. Its Intelligent Cloud segment licenses server products and cloud services, such as SQL Server, Windows Server, Visual Studio, System Center, and related CALs, as well as Azure, a cloud platform with computing, networking, storage, database, and management services; and enterprise services, such as Premier Support and Microsoft Consulting that assist in developing, deploying, and managing Microsoft server and desktop solutions, as well as provide training and certification to developers and IT professionals on Microsoft products. The company’s More Personal Computing segment comprises Windows OEM, volume, and other non-volume licensing of the Windows operating system, as well as patent licensing, Windows Embedded, MSN display advertising, and Windows Phone licensing system; devices, including Microsoft Surface, phones, and PC accessories; and search advertising, including Bing and Bing Ads. This segment also provides gaming platforms, including Xbox hardware, Xbox Live, video games, and third-party video games. The company markets and distributes its products through original equipment manufacturers (OEM), distributors, and resellers, as well as through online and Microsoft retail stores. Microsoft Corporation was founded in 1975 and is headquartered in Redmond, Washington.

 

Momentum Stocks: NextEra Energy, Inc. (NEE), The Travelers Companies, Inc. (TRV), DENTSPLY SIRONA Inc. (XRAY)

NextEra Energy, Inc. (NEE) grew with the stock adding 0.66% or $0.82 to close at $125.47 on light trading volume of 1.21M compared its three months average trading volume of 2.32M. The Juno Beach Florida 33408 based company operating under the Electric Utilities industry has been trending up for the last 52 weeks, with the shares price now 15.48% up for the period and up by 5.03% so far this year. With price target of $136.33 and a 17.3% rebound from 52-week low, NextEra Energy, Inc. has plenty of upside potential, making it a hold with a view buy.

NextEra Energy, Inc., through its subsidiaries, generates, transmits, and distributes electric energy in the United States and Canada. The company generates electricity from gas, oil, solar, coal, petroleum coke, nuclear, and wind sources. As of December 31, 2015, it served approximately 9.5 million people through approximately 4.8 million customer accounts in the east and lower west coasts of Florida. The company had approximately 46,400 megawatts of generating capacity. It also leases fiber-optic network capacity and dark fiber to telephone, wireless, and Internet companies. The company was formerly known as FPL Group, Inc. and changed its name to NextEra Energy, Inc. in 2010. NextEra Energy, Inc. was founded in 1984 and is headquartered in Juno Beach, Florida.

The Travelers Companies, Inc. (TRV) had a light trading with around 1.2M shares changing hands compared to its three month average trading volume of 1.64M. The stock traded between $118.99 and $120.21 before closing at the price of $119.73 with 0.8% change on the day. The New York New York 10017 based company is currently trading 18.84% above its 52 week low of $103.45 and -2.73% below its 52 week high of $123.09. Both the RSI indicator and target price of  and $121.73 respectively, lead us to believe that it could rise over the coming weeks.

The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United states and internationally. The company operates in three segments: Business and International Insurance; Bond & Specialty Insurance; and Personal Insurance. The Business and International Insurance segment offers property and casualty products, including commercial multi-peril, commercial property, general liability, commercial automobile, and workers’ compensation; and personal property, employers’ liability, public and product liability, professional indemnity, commercial property, surety, marine, aviation, personal accident, and kidnap and ransom insurance. This segment operates through select accounts, which serve small businesses; commercial accounts that serve mid-sized businesses; national accounts, which serve large companies; first party that provides traditional and customized property insurance programs to large and mid-sized customers; and specialized distribution, which markets and underwrites its products through brokers, wholesale agents, program managers, and specialized retail agents. The Bond & Specialty Insurance segment provides fidelity and surety, general liability, and others, such as property, workers’ compensation, commercial automobile, and commercial multi-peril insurance products. The Personal Insurance segment offers property and casualty insurance covering personal risks, primarily automobile and homeowners insurance to individuals. The company distributes its products primarily through independent agencies and brokers. The Travelers Companies, Inc. was founded in 1853 and is based in New York, New York.

DENTSPLY SIRONA Inc. (XRAY) saw its value decrease by -0.38% as the stock dropped $-0.22 to finish the day at a closing price of $58.39. The stock was lighter in trading and has fluctuated between $54.05-$65.83 per share for the past year. The shares, which traded within a range of $58.26 to $58.75 during the day, are down by -4.45% in the past three months and down by -4.71% over the past six months. It is currently trading 2.68% above its 20 day moving average and 0.72% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $66.5 a share over the next twelve months. The current relative strength index (RSI) reading is 57.95.The technical indicator lead us to believe there will be no major movement any time soon, hold.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

 

Trader’s Round Up: Public Service Enterprise Group Incorporated (PEG), T. Rowe Price Group, Inc. (TROW), DENTSPLY SIRONA Inc. (XRAY)

Public Service Enterprise Group Incorporated (PEG) retreated with the stock falling -0.59% or $-0.26 to close at $43.45 on light trading volume of 1.87M compared its three months average trading volume of 2.48M. The Newark New Jersey 07102 based company operating under the Diversified Utilities industry has been trending up for the last 52 weeks, with the shares price now 5.16% up for the period and down by -0.98% so far this year. With price target of $45.91 and a 11.72% rebound from 52-week low, Public Service Enterprise Group Incorporated has plenty of upside potential, making it a hold with a view buy.

Public Service Enterprise Group Incorporated, through its subsidiaries, operates as an energy company primarily in the Northeastern and Mid- Atlantic United States. The company operates nuclear, coal, gas, oil-fired, and renewable generation facilities with a generation capacity of approximately 11,678 megawatts. It sells electricity, natural gas, emissions credits, and a series of energy-related products. The company also transmits electricity; and distributes electricity and gas to residential, commercial, and industrial customers, as well as invests in solar generation projects, and implements energy efficiency and demand response programs. In addition, it offers appliance services and repairs to customers. As of December 31, 2015, the company’s electric transmission and distribution system included 24,022 circuit miles, of which 8,226 circuit miles were underground; and 848,496 poles, of which 549,636 poles were jointly-owned, as well as 4 electric distribution headquarters and 5 sub-headquarters. It also owned and operated 18,112 miles of gas mains; owned 12 gas distribution headquarters and 2 sub-headquarters; owned 1 meter shop; operated 60 natural gas metering and regulating stations; and owned 43 switching stations with an aggregate installed capacity of 29,090 megavolt-amperes (MVA) and 246 substations with an aggregate installed capacity of 8,179 MVA. Public Service Enterprise Group Incorporated was founded in 1985 and is headquartered in Newark, New Jersey.

  1. Rowe Price Group, Inc. (TROW) dropped $-0.38 to close the day at a new closing price of $67.33, a -0.56% decrease in value from its previous closing price that moved the stock 7.96% above its 52 week low of $62.97. A total of 1.86M shares exchanged hands during the day compared with its three month average trading volume of 2.1M. The stock, which fluctuated between $66.7 and $68 during the day, currently situated -14.11% below its 52 week high. The stock is down by -11.84% in the past one month and up by 6.47% over the past three months. With a one year target estimate of $73.05 and RSI of 30.79, the stock still has upside potential, making it a hold for now.
  2. Rowe Price Group, Inc. is a publicly owned investment manager. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It launches and manages equity and fixed income mutual funds. The firm invests in the public equity and fixed income markets across the globe. It employs fundamental and quantitative analysis with a bottom-up approach. The firm utilizes in-house and external research to make its investments. It employs socially responsible investing with a focus on environmental, social, and governance issues. It makes investment in late-stage venture capital transactions and usually invests between $3 million and $5 million. The firm was previously known as T. Rowe Group, Inc. and T. Rowe Price Associates, Inc. T. Rowe Price Group, Inc. was founded in 1937 and is based in Baltimore, Maryland, with additional offices in Colorado Springs, Colorado; Owings Mills, Maryland; San Francisco, California; Tampa, Florida; Toronto, Ontario; Hellerup, Denmark; Amsterdam, The Netherlands; Luxembourg, Grand Duchy of Luxembourg; Zurich, Switzerland; Dubai, United Arab Emirates; London, United Kingdom; Sydney, New South Wales; Hong Kong; Tokyo, Japan; Singapore; Frankfurt, Germany, Madrid, Spain, Milan, Italy, Stockholm, Sweden, Melbourne, Australia, and Amsterdam, Netherlands.

DENTSPLY SIRONA Inc. (XRAY) shares were up in last trading by 0.21% to $57.26. It experienced higher than average volume on day. The stock increased in value by almost 1.63% over the past week and fell -1.83% in the past month. It is currently trading -1.59% below its 50 day moving average and -4.85% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -12.68% decrease in value from its one year high of $65.83. The RSI indicator value of 51.38, lead us to believe that it is a hold for now.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

 

Stocks To Track: DENTSPLY SIRONA Inc. (XRAY), Becton, Dickinson and Company (BDX), Humana Inc. (HUM)

DENTSPLY SIRONA Inc. (XRAY) fell -0.67% during last trading as the stock lost $-0.38 to finish the day at $56.52 with about 1.29M shares changing hands, compared to its three month average trading volume of 1.67M. The $13.05B market cap company, which fluctuated between $56.21 and $56.87 during the day, currently situated 6.33% above its 52 week low of $53.43 and -13.81% away from its one year high of $65.83. The RSI of 45.94 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Becton, Dickinson and Company (BDX) dropped $-1 to close the day at a new closing price of $177.97, a -0.56% decrease in value from its previous closing price that moved the stock 39.71% above its 52 week low of $129.5. A total of 1.29M shares exchanged hands during the day compared with its three month average trading volume of 1.18M. The stock, which fluctuated between $176.74 and $181.44 during the day, currently situated -1.65% below its 52 week high. The stock is up by 7.76% in the past one month and up by 7.45% over the past three months. With a one year target estimate of $186.33 and RSI of 69.61, the stock still has upside potential, making it a hold for now.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women’s health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Humana Inc. (HUM) had a light trading with around 1.29M shares changing hands compared to its three month average trading volume of 1.73M. The stock traded between $196.06 and $200.14 before closing at the price of $199.39 with 0.46% change on the day. The Louisville Kentucky 40202 based company is currently trading 33.33% above its 52 week low of $150 and -8.32% below its 52 week high of $217.8. Both the RSI indicator and target price of 43.16 and $224.31 respectively, lead us to believe that it should be put on hold over the coming weeks.

Humana Inc., together with its subsidiaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment offers Medicare, and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; and administrative services only, and health and wellness products to employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment offers pharmacy solutions, provider services, home based services, clinical programs, and predictive modeling and informatics services to its health plan members, as well as to third parties. The company also provides closed-block long-term care insurance policies. As of December 31, 2015, it had approximately 14.2 million members in medical benefit plans, as well as approximately 7.2 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

 

Trader’s Round Up: TD Ameritrade Holding Corporation (AMTD), DENTSPLY SIRONA Inc. (XRAY), Alphabet Inc. (GOOG)

TD Ameritrade Holding Corporation (AMTD) retreated with the stock falling -0.32% or $-0.15 to close at $46.15 on light trading volume of 1.67M compared its three months average trading volume of 2.51M. The Omaha Nebraska 68154 based company operating under the Investment Brokerage – National industry has been trending up for the last 52 weeks, with the shares price now 71.09% up for the period and up by 6.26% so far this year. With price target of $49.19 and a 89.32% rebound from 52-week low, TD Ameritrade Holding Corporation has plenty of upside potential, making it a hold with a view buy.

TD Ameritrade Holding Corporation provides securities brokerage services and related technology-based financial services to retail investors, traders, and independent registered investment advisors (RIAs) in the United States. Its products and services include tdameritrade.com, a Web platform for self-directed retail investors; Trade Architect, a Web-based platform for investors and traders to identify opportunities and stay informed; thinkorswim, a desktop platform for traders; and TD Ameritrade Mobile, which allows on-the-go investors and traders to trade and monitor accounts. The company also offers TD Ameritrade Institutional that provides brokerage and custody services to approximately 5,000 independent RIAs and their clients; TD Ameritrade’s Goal Planning, which offers investment consulting and planning services; Investools, a suite of investor education products and services for stock, option, foreign exchange, futures, mutual fund, and fixed-income investors; Amerivest, an advisory service that develops portfolios of exchange-traded funds (ETFs) and mutual funds; AdvisorDirect, a national referral service for investors; and TD Ameritrade Corporate Services that provide self-directed brokerage services to employees of corporations. In addition, it offers various retail brokerage products and services, such as common and preferred stocks; ETFs; options; futures; foreign exchange; mutual funds; fixed income products; primary and secondary offerings of fixed income securities, closed-end funds, and preferred stocks; margin lending; cash management services; and annuities. The company provides its services primarily through the Internet, a network of retail branches, mobile trading applications, interactive voice response, and registered representatives through telephone. TD Ameritrade Holding Corporation was founded in 1971 and is headquartered in Omaha, Nebraska. TD Ameritrade Holding Corporation is a subsidiary of The Toronto-Dominion Bank.

DENTSPLY SIRONA Inc. (XRAY) gained $0.36 to close the day at a new closing price of $56.7, a 0.64% increase in value from its previous closing price that moved the stock 6.67% above its 52 week low of $53.43. A total of 2.24M shares exchanged hands during the day compared with its three month average trading volume of 1.68M. The stock, which fluctuated between $55.97 and $56.72 during the day, currently situated -13.54% below its 52 week high. The stock is down by -2.66% in the past one month and down by -0.48% over the past three months. With a one year target estimate of $67.17 and RSI of 45.5, the stock still has upside potential, making it a hold for now.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Alphabet Inc. (GOOG) shares were down in last trading by -0.69% to $796.79. It experienced higher than average volume on day. The stock decreased in value by almost -3.29% over the past week and grew 1.79% in the past month. It is currently trading 1.01% above its 50 day moving average and 5.13% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -5.36% decrease in value from its one year high of $841.95. The RSI indicator value of 47.14, lead us to believe that it is a hold for now.

Alphabet Inc., through its subsidiaries, provides online advertising services in the United States, the United Kingdom, and rest of the world. The company offers performance and brand advertising services. It operates through Google and Other Bets segments. The Google segment includes principal Internet products, such as Search, Ads, Commerce, Maps, YouTube, Apps, Cloud, Android, Chrome, and Google Play, as well as technical infrastructure and newer efforts, such as Virtual Reality. This segment also sells hardware products comprising Chromecast, Chromebooks, and Nexus. The Other Bets segment includes businesses, such as Access/Google Fiber, Calico, Nest, Verily, GV, Google Capital, X, and other initiatives. Alphabet Inc. was founded in 1998 and is headquartered in Mountain View, California.

 

Stocks in Focus: DENTSPLY SIRONA Inc. (XRAY), E. I. du Pont de Nemours and Company (DD), Thermo Fisher Scientific Inc. (TMO)

DENTSPLY SIRONA Inc. (XRAY) had a active trading with around 2.14M shares changing hands compared to its three month average trading volume of 1.67M. The stock traded between $55.79 and $56.78 before closing at the price of $56.57 with -0.05% change on the day. The York Pennsylvania 17405 based company is currently trading 6.43% above its 52 week low of $53.43 and -13.73% below its 52 week high of $65.83. Both the RSI indicator and target price of 41.66 and $67.17 respectively, lead us to believe that it should be put on hold over the coming weeks.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

  1. I. du Pont de Nemours and Company (DD) failed to extend gains with the stock declining -0.37% or $-0.29 to close the day at $77.7 on light trading volume of 2.11M shares, compared to its three month average trading volume of 2.95M. The company has been outperforming the agricultural chemicals group over the past 52 weeks, with the stock gaining 52.91%, compared to the industry which has advanced 33.69% over the same period. With RSI of 71.25, the stock should still continue to rise and get closer to its one year target estimate of $79.31, making it a hold for now.
  2. I. du Pont de Nemours and Company operates as a science and technology based company. The company’s Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, wheat, rice, seed products, herbicides, fungicides, and insecticides, as well as offers crop protection products, such as weed control, disease control, and insect control products. Its Electronics & Communications segment provides various materials and systems, including photopolymers and electronic materials for photovoltaic, consumer electronics, displays, and advanced printing. The company’s Industrial Biosciences segment develops and manufactures a portfolio of enzymes and bio-based materials. Its Nutrition & Health segment offers cultures, probiotics, texturants, emulsifiers, natural sweeteners, and soy-based food ingredients for the food industry market. The company’s Performance Materials segment offers elastomers and thermoplastic, and thermoset engineering polymers; resins and films for packaging and industrial polymer applications, sealants and adhesives, and sporting goods; and elastomers, parts, and systems and solutions for automotive and transportation, packaging for food and beverages, electrical/electronic components, material handling, healthcare, construction, semiconductor, and aerospace markets. Its Safety & Protection segment provides nonwovens, aramids, and solid surfaces for the construction, transportation, communications, industrial chemicals, oil and gas, electric utilities, automotive, manufacturing, defense, homeland security, and safety consulting industries. The company markets its products through the company’s sales force and distributors in the United States and internationally. E. I. du Pont de Nemours and Company was founded in 1802 and is headquartered in Wilmington, Delaware.

Thermo Fisher Scientific Inc. (TMO) shares were up in last trading by 1.64% to $145.45. It experienced higher than average volume on day. The stock increased in value by almost 1.35% over the past week and grew 2.13% in the past month. It is currently trading 1.17% above its 50 day moving average and -2.6% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -9.29% decrease in value from its one year high of $160.68. The RSI indicator value of 57.16, lead us to believe that it is a hold for now.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company’s Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company’s Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

 

Momentum Stocks: Molson Coors Brewing Company (TAP), Fortive Corporation (FTV), DENTSPLY SIRONA Inc. (XRAY)

Molson Coors Brewing Company (TAP) grew with the stock adding 0.11% or $0.11 to close at $96.99 on active trading volume of 1.77M compared its three months average trading volume of 1.69M. The Denver Colorado 80202 based company operating under the Beverages – Brewers industry has been trending up for the last 52 weeks, with the shares price now 12.4% up for the period and down by -0.33% so far this year. With price target of $120.2 and a 22.12% rebound from 52-week low, Molson Coors Brewing Company has plenty of upside potential, making it a hold with a view buy.

Molson Coors Brewing Company manufactures and sells beer and other beverage products. The company sells its products under the Coors Light, Molson Canadian, Belgian Moon, Carling, Carling Black Label, Coors Altitude, Coors Banquet, Creemore Springs, the Granville Island, Keystone, Mad Jack, Molson Canadian 67, Molson Canadian Cider, Molson Dry, Molson Export, Pilsner, and the Rickard’s family brands in Canada; and brews or distributes under the Amstel Light, Heineken, Murphy’s, Newcastle Brown Ale, Strongbow cider, Desperados, Dos Equis, Moretti, Sol, and Tecate brands. It also sells various brands in the United States and Puerto Rico, such as Coors Light, Miller Lite, MillerCoors, Coors Banquet, Coors Peak, Hamm’s, Keystone Light, Icehouse, Mickey’s, Miller 64, Miller Fortune, Miller Genuine Draft, Miller High Life, Milwaukee’s Best, Old English 800, Steel Reserve, Grolsch, Peroni Nastro Azzurro, Pilsner Urquell, Crispin, Smith & Forge, Blue Moon, and Jacob Leinenkugel Brewing Company brands, as well as Henry’s hard sodas; and brews or distributes under the George Killian’s Irish Red, Redd’s, Foster’s, and Molson brands. In addition, the company sells Carling, Staropramen, Apatinsko, Astika, Bergenbier, Borsodi, Branik, Coors Light, Jelen, Kamenitza, Niksicko, Noroc, Ostravar, Ozujsko, Sharp’s Doom Bar, Worthington’s, Beck’s, Belle-Vue Kriek, Hoegaarden, Leffe, Lowenbrau, Löwenweisse, Spaten, Stella Artois, Corona Extra, Rekorderlig cider, Cobra, Grolsch, Singha, and other Modelo brands; and regional ale and factored brands in Europe. Further, it sells Carling, Coors Light, Staropramen, Blue Moon, Cobra, Corona, Molson Canadian, Carling Strong, Coors, Coors 1873, Coors Extra, Coors Gold, Iceberg 9000, King Cobra, Royal Brew, Thunderbolt, and Zima brands. The company was formerly known as Adolph Coors Company and changed its name to Molson Coors Brewing Company in February 2005. The Company was founded in 1786 and is headquartered in Denver, Colorado.

Fortive Corporation (FTV) had a active trading with around 1.76M shares changing hands compared to its three month average trading volume of 1.6M. The stock traded between $54.7 and $55.34 before closing at the price of $55.17 with 0.86% change on the day. The Everett Washington 98203 based company is currently trading 19.5% above its 52 week low of $46.29 and -1.9% below its 52 week high of $56.24. Both the RSI indicator and target price of  and $57.5 respectively, lead us to believe that it could rise over the coming weeks.

Fortive Corporation, through its subsidiaries, manufactures and markets industrial products. The company offers field instrumentation, sensing, product realization, and automation and specialty solutions. Fortive Corporation was founded in 2016 and is based in Everett, Washington. Fortive operates independently of Danaher Corp. as of July 02, 2016.

DENTSPLY SIRONA Inc. (XRAY) saw its value increase by 1.25% as the stock gained $0.7 to finish the day at a closing price of $56.91. The stock was higher in trading and has fluctuated between $53.43-$65.83 per share for the past year. The shares, which traded within a range of $56.25 to $57.04 during the day, are down by -1.72% in the past three months and down by -9.53% over the past six months. It is currently trading -1.36% below its 20 day moving average and -3.1% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $67.33 a share over the next twelve months. The current relative strength index (RSI) reading is 43.51.The technical indicator lead us to believe there will be no major movement any time soon, hold.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

 

Stocks Roundup: DENTSPLY SIRONA Inc. (XRAY), Royal Caribbean Cruises Ltd. (RCL), Danaher Corporation (DHR)

DENTSPLY SIRONA Inc. (XRAY) retreated with the stock falling -0.75% or $-0.42 to close at $55.59 on active trading volume of 2.38M compared its three months average trading volume of 1.63M. The York Pennsylvania 17405 based company operating under the Medical Instruments & Supplies industry has been trending down for the last 52 weeks, with the shares price now -2.85% down for the period and down by -3.71% so far this year. With price target of $67.33 and a 4.58% rebound from 52-week low, DENTSPLY SIRONA Inc. has plenty of upside potential, making it a hold with a view buy.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Royal Caribbean Cruises Ltd. (RCL) had a active trading with around 2.37M shares changing hands compared to its three month average trading volume of 1.9M. The stock traded between $84.52 and $85.18 before closing at the price of $84.96 with -0.09% change on the day. The Miami Florida 33132 based company is currently trading 35.32% above its 52 week low of $64.21 and -2.1% below its 52 week high of $86.84. Both the RSI indicator and target price of  and $92.68 respectively, lead us to believe that it could rise over the coming weeks.

Royal Caribbean Cruises Ltd. operates as a cruise company. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, Pullmantur, Azamara Club Cruises, CDF Croisières de France, and TUI Cruises brand names. The Royal Caribbean International brand provides cruise itineraries ranging from 2 to 24 nights with options for onboard dining, entertainment, and other onboard activities to various destinations. The Celebrity Cruises brand offers cruise itineraries ranging from 2 to 18 nights to various destinations; and operates onboard upscale ships that offer accommodations, fine dining, personalized services, and spa facilities. The Azamara Club Cruises brand offers cruise itineraries ranging from 3 to 20 nights that serve the up-market segment of the North American, the United Kingdom, and Australian markets. The Pullmantur brand provides cruise itineraries ranging from 2 to 15 nights with food and entertainment options for families and couples. The CDF Croisières de France brand offers seasonal itineraries to the Mediterranean, Europe, and Caribbean markets. The TUI Cruises brand provides onboard activities, services, shore excursions, and menu offerings for the German cruise market. As of December 31, 2015, the company operated 44 ships with itineraries ranging from 2 to 24 nights on approximately 490 destinations worldwide. Royal Caribbean Cruises Ltd. was founded in 1968 and is headquartered in Miami, Florida.

Danaher Corporation (DHR) saw its value decrease by -0.66% as the stock dropped $-0.53 to finish the day at a closing price of $80. The stock was lighter in trading and has fluctuated between $61.6-$82.64 per share for the past year. The shares, which traded within a range of $79.86 to $80.5 during the day, are down by -0.07% in the past three months and down by -1.21% over the past six months. It is currently trading 0.28% above its 20 day moving average and 1.1% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $89.26 a share over the next twelve months. The current relative strength index (RSI) reading is 50.62.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Its Test & Measurement segment provides instruments products; services and products that help to convert concepts into finished products; professional tools; and wheel service equipment. The company’s Environmental segment provides instrumentation and disinfection systems; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale and payment system, environmental compliance, vehicle tracking, and fleet management. Its Life Sciences & Diagnostics segment offers chemistry systems, immunoassay systems, hematology and flow cytometry products, microbiology systems, and systems and workflow automations solutions. This segment also provides professional microscopes; mass spectrometers; bioanalytical measurement systems; workflow instruments and consumables; and filtration products, which are used to remove solid, liquid, and gaseous contaminants. The company’s Dental segment offers consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. The company’s Industrial Technologies segment provides equipment, consumables, and software for various printing, marking, coding, packaging, design, and color management applications; and a range of electromechanical and electronic motion control products. This segment also offers devices that sense, monitor and control operational or manufacturing variables; instruments, controls, and monitoring systems used in electric utilities and industrial facilities; engineered energetic materials components; and supplemental braking systems for commercial vehicles. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

 

3 Stocks in Focus: DENTSPLY SIRONA Inc. (XRAY), Celgene Corporation (CELG), General Growth Properties, Inc (GGP)

DENTSPLY SIRONA Inc. (XRAY) climbed 0.61% during last trading as the stock added $0.34 to finish the day at $56.01 with about 5.27M shares changing hands, compared to its three month average trading volume of 1.57M. The $12.85B market cap company, which fluctuated between $55 and $56.03 during the day, currently situated 5.37% above its 52 week low of $53.43 and -14.59% away from its one year high of $65.83. The RSI of 34.89 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Celgene Corporation (CELG) dropped $-0.96 to close the day at a new closing price of $112.66, a -0.84% decrease in value from its previous closing price that moved the stock 21.07% above its 52 week low of $93.05. A total of 5.25M shares exchanged hands during the day compared with its three month average trading volume of 4.97M. The stock, which fluctuated between $112.42 and $114.75 during the day, currently situated -11.29% below its 52 week high. The stock is down by -2.65% in the past one month and up by 12.64% over the past three months. With a one year target estimate of $138.67 and RSI of 34.5, the stock still has upside potential, making it a hold for now.

Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID to treat multiple myeloma; and OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis, psoriasis, ankylosing spondylitis, Behçet’s disease, atopic dermatitis, and ulcerative colitis. The company’s products also include VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); THALOMID for the patients with multiple myeloma and erythema nodosum leprosum; ISTODAX to treat cutaneous and peripheral T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN products. Its clinical stage products include OTEZLA for the treatment of various immune-inflammatory diseases; sotatercept for the treatment of renal anemia, beta-thalassemia and MDS; luspatercept for beta-thalassemia and MDS; CC-486 to treat MDS, AML, and solid tumors; CC-122 and CC-220 to treat hematological and solid tumor cancers, and inflammation and immunology diseases; PDA-002 for the treat diabetic foot ulcers and peripheral neuropathy; and PNK-007 for hematological malignancies treatment. The company has collaborative agreements with Novartis Pharma AG; Acceleron Pharma; Agios Pharmaceuticals, Inc.; Epizyme Inc.; Sutro Biopharma, Inc.; bluebird bio, Inc.; FORMA Therapeutics Holdings, LLC; Acetylon Pharmaceuticals, Inc.; OncoMed Pharmaceuticals, Inc.; NantBioScience, Inc.; AstraZeneca PLC; Lycera Corp.; Juno Therapeutics, Inc.; TriNetX, Inc.; Triphase Accelerator Corporation; Nurix Inc.; Abbott; Sage Bionetworks; and PharmAkea Inc. The company was founded in 1980 and is headquartered in Summit, New Jersey.

General Growth Properties, Inc (GGP) had a active trading with around 5.22M shares changing hands compared to its three month average trading volume of 4.32M. The stock traded between $24.35 and $25 before closing at the price of $24.99 with 1.46% change on the day. The Chicago Illinois 60606 based company is currently trading 4.6% above its 52 week low of $23.89 and -22.15% below its 52 week high of $32.1. Both the RSI indicator and target price of 47.07 and $30.21 respectively, lead us to believe that it should be put on hold over the coming weeks.

General Growth Properties, Inc is an equity real estate investment trust. The firm invests in the real estate markets of the United States. It engages in owning, managing, leasing, and redeveloping high-quality regional malls. General Growth Properties, Inc is based in Chicago, Illinois.